Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2016/02/006623
CTRI/2016/02/006623
Completed
Phase 4

A Randomized placebo controlled pharmaco-clinical study of Sharapunkhadi Yoga and lifestyle modification in the management of Non Alcoholic Fatty Liver Disease - NAFLD ( Non Alcoholic Fatty Liver Disease)

IPGT AND RA0 sites93 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedHealth Condition 2: null- USG findings suggestive of NAFLD Grade I, II & III

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedHealth Condition 2: null- USG findings suggestive of NAFLD Grade I, II & III
Sponsor
IPGT AND RA
Enrollment
93
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 30, 2017
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
IPGT AND RA

Eligibility Criteria

Inclusion Criteria

  • •Patients of either sex of age group above 25 yrs and below 60yrs
  • •USG findings suggestive of Non Alcoholic Fatty Liver Disease grade I II III
  • •Both freshly detected and previously diagnosed cases of NAFLD

Exclusion Criteria

  • •Patient aged below 25 years and above 60 years pregnant ladies
  • •Patients with uncontrolled diabetes or hypertension
  • •Patients with complications of Metabolic syndrome like Cerebrovascular accident Myocardial Infarction Chronic Kidney disease
  • •Patients consuming hepatotoxic medicines alcohol or other narcotic substances
  • •Patients suffering from Cirrhosis Ascites variceal haemorrhage coagulopathy hepato renal syndrome
  • •Patients having history of viral hepatitis auto immune liver diseases like Primary biliary cirrhosis primary sclerosing cholangitis autoimmune hepatitis metabolic disorders like Wilsons disease haemochromatosis
  • •Patients suffering from HIV TB other infectious diseases malignancies major psychiatric problems or any other serious illnesses

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomized placebo controlled clinical trial of a rehabilitation programme for patients with a diagnosis of massive, irreparable rotator cuff tears of the shoulder
ISRCTN64734872Record Provided by the NHSTCT Register - 2006 Update - Department of Health60
Active, not recruiting
Not Applicable
A randomized placebo-controlled clinical trial of topical photodynamic therapy with a nanoemulsion formulation of 5-aminolevulinic acid for the treatment of actinic keratosis
EUCTR2006-000314-20-DEBiofrontera Bioscience GmbH260
Suspended
Not Applicable
To study the effect of Tofacitinib along with corticosteroids in patients with acute severe ulcerative colitis.Health Condition 1: K519- Ulcerative colitis, unspecified
CTRI/2022/08/044613Dr Ajit Sood
Active, not recruiting
Phase 1
Clinical study in adults and young patients with Primary Sclerosing Cholangitis treated with oral vancomycin or placebo
CTIS2023-507425-42-00niversity Of Milano Bicocca84
Not yet recruiting
Phase 2
Clinical study on the effect of Navayas Lauha (an ayurvedic classical formulation) and specific diet in the management of obesity(sthaulya)
CTRI/2024/02/062731G J Patel Institute of Ayurvedic Studies and Research